286 related articles for article (PubMed ID: 25411513)
21. IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy.
Fang S; Huang Y; Zhong S; Zhang Y; Liu X; Wang Y; Gu P; Zhou H; Fan X
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6123-6133. PubMed ID: 27832278
[TBL] [Abstract][Full Text] [Related]
22. Intersection of Chemokine and TSH Receptor Pathways in Human Fibrocytes: Emergence of CXCL-12/CXCR4 Cross Talk Potentially Relevant to Thyroid-Associated Ophthalmopathy.
Fernando R; Atkins SJ; Smith TJ
Endocrinology; 2016 Oct; 157(10):3779-3787. PubMed ID: 27471912
[TBL] [Abstract][Full Text] [Related]
23. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
[TBL] [Abstract][Full Text] [Related]
24. Peripheral blood mononuclear cells - Can they provide a clue to the pathogenesis of Graves' Orbitopathy?
Basak M; Sanyal T; Kar A; Bhattacharjee P; Das M; Chowdhury S
Endocrine; 2022 Feb; 75(2):447-455. PubMed ID: 34545512
[TBL] [Abstract][Full Text] [Related]
25. [Gene and protein expression of thyrotropin-receptor in retro-bulbar tissue from thyroid-associated ophthalmopathy].
Sun FY; Pan Y; Song GX; Chang JW
Zhonghua Yan Ke Za Zhi; 2006 Feb; 42(2):155-8. PubMed ID: 16643732
[TBL] [Abstract][Full Text] [Related]
26. Slit2 May Underlie Divergent Induction by Thyrotropin of IL-23 and IL-12 in Human Fibrocytes.
Fernando R; Atkins SJ; Smith TJ
J Immunol; 2020 Apr; 204(7):1724-1735. PubMed ID: 32086386
[TBL] [Abstract][Full Text] [Related]
27. PI3K/AKT pathway mediates induction of IL-1RA by TSH in fibrocytes: modulation by PTEN.
Li B; Smith TJ
J Clin Endocrinol Metab; 2014 Sep; 99(9):3363-72. PubMed ID: 24840811
[TBL] [Abstract][Full Text] [Related]
28. Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.
Smith TJ; Hegedüs L; Douglas RS
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):291-302. PubMed ID: 22632366
[TBL] [Abstract][Full Text] [Related]
29. Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2011 Feb; 21(2):169-76. PubMed ID: 20954819
[TBL] [Abstract][Full Text] [Related]
30. CD34- Orbital Fibroblasts From Patients With Thyroid-Associated Ophthalmopathy Modulate TNF-α Expression in CD34+ Fibroblasts and Fibrocytes.
Lu Y; Atkins SJ; Fernando R; Trierweiler A; Mester T; Grisolia ABD; Mou P; Novaes P; Smith TJ
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2615-2622. PubMed ID: 29847668
[TBL] [Abstract][Full Text] [Related]
31. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.
Tsui S; Naik V; Hoa N; Hwang CJ; Afifiyan NF; Sinha Hikim A; Gianoukakis AG; Douglas RS; Smith TJ
J Immunol; 2008 Sep; 181(6):4397-405. PubMed ID: 18768899
[TBL] [Abstract][Full Text] [Related]
32. Fibrocyte Participation in Thyroid-Associated Ophthalmopathy Suggests New Approaches to Therapy.
Smith TJ
Ophthalmic Plast Reconstr Surg; 2023 Dec; 39(6S):S9-S18. PubMed ID: 38054981
[TBL] [Abstract][Full Text] [Related]
33. Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy.
Fernando R; Placzek E; Reese EA; Placzek AT; Schwartz S; Trierweiler A; Niziol LM; Raychaudhuri N; Atkins S; Scanlan TS; Smith TJ
J Clin Endocrinol Metab; 2017 Mar; 102(3):776-785. PubMed ID: 27768856
[TBL] [Abstract][Full Text] [Related]
34. A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy.
Turcu AF; Kumar S; Neumann S; Coenen M; Iyer S; Chiriboga P; Gershengorn MC; Bahn RS
J Clin Endocrinol Metab; 2013 May; 98(5):2153-9. PubMed ID: 23482611
[TBL] [Abstract][Full Text] [Related]
35. TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist.
Chen H; Shan SJ; Mester T; Wei YH; Douglas RS
PLoS One; 2015; 10(6):e0130322. PubMed ID: 26087256
[TBL] [Abstract][Full Text] [Related]
36. Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation.
Agretti P; De Marco G; De Servi M; Marcocci C; Vitti P; Pinchera A; Tonacchera M
Eur J Endocrinol; 2005 May; 152(5):777-84. PubMed ID: 15879364
[TBL] [Abstract][Full Text] [Related]
37. Slit2 Regulates Hyaluronan & Cytokine Synthesis in Fibrocytes: Potential Relevance to Thyroid-Associated Ophthalmopathy.
Fernando R; Smith TJ
J Clin Endocrinol Metab; 2021 Jan; 106(1):e20-e33. PubMed ID: 32968816
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
Lim HS; Back KO; Kim HJ; Choi YH; Park YM; Kook KH
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7441-50. PubMed ID: 25342622
[TBL] [Abstract][Full Text] [Related]
39. Regulation of IL-1 receptor antagonist by TSH in fibrocytes and orbital fibroblasts.
Li B; Smith TJ
J Clin Endocrinol Metab; 2014 Apr; 99(4):E625-33. PubMed ID: 24446657
[TBL] [Abstract][Full Text] [Related]
40. [Bone marrow-derived fibrocytes and thyroid-associated opthalmopathy].
Wu T; Tang DR; Sun FY
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):470-473. PubMed ID: 28606271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
